Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3566668

Documents

Beta release

Statistics of Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Statistics for this year
PeriodVisitsDownloads
20243627
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0722
2024-0832
2024-0900